The patient's tumor response (IMAGE)

Sichuan International Medical Exchange and Promotion Association

The patient's tumor response

Caption

The high DCR(97.5%) and ORR(32.5%) indicate that this combination regimen has a superior clinical effect in the management of HR+/HER2+ metastatic breast cancer, and it is an important alternative treatment option especially for patients who cannot tolerate conventional chemotherapy.

Credit

Ying Wang

Usage Restrictions

Please cite source

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.